Internal Medicine · Los Angeles, CA
NPI
1598881179
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
809 N Hill St, #k
Los Angeles, CA, 90012
Phone (213) 346-9982
Groups this clinician bills Medicare through
Medicare paid, 2024
$457K
11,169 services
Medicare patients, 2024
590
Average age 79
Drug cost, 2024
$4.8M
23,343 prescriptions
Company payments, 2025
$6,176
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nick Lee was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,927 times for 480 patients. In total Nick Lee billed 11,169 services in 51 codes, and Medicare paid $457K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,927 | 480 | $12.68 | $24K |
| 99213 Office E&M - Established | Office | 1,853 | 471 | $71.40 | $132K |
| 99442 Telephone Services | Office | 801 | 283 | $53.03 | $42K |
| 99214 Office E&M - Established | Office | 735 | 326 | $104.30 | $77K |
| 97110 PT Treatment | Office | 610 | 72 | $18.62 | $11K |
| 97035 PT Treatment | Office | 609 | 72 | $8.88 | $5,406 |
| 97124 PT Treatment | Office | 607 | 71 | $25.06 | $15K |
| G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 604 | 71 | $7.46 | $4,508 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 323 | 55 | $0.75 | $241 |
| 36415 Venipuncture Blood Collection | Office | 298 | 231 | $8.65 | $2,578 |
| 96372 Injection Administration | Office | 279 | 147 | $12.04 | $3,359 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 279 | 279 | $21.08 | $5,882 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 277 | 277 | $26.82 | $7,429 |
| 99497 Care Management/Coordination | Office | 264 | 261 | $85.03 | $22K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 260 | 260 | $21.10 | $5,487 |
By year: 2022 $493K for 10,018 services; 2023 $465K for 9,968 services; 2024 $457K for 11,169 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 298 | 231 | $8.65 | $2,578 |
Medicare prescription drug claims, 2024
In 2024, the drug Nick Lee prescribed most often to Medicare patients was Rosuvastatin Calcium, with 926 prescriptions and refills. In total Nick Lee wrote 23,343 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 926 | 1,332 | 208 | $4,081 |
| Atorvastatin Calcium Generic | 854 | 1,225 | 184 | $3,683 |
| Montelukast Sodium Generic | 775 | 948 | 243 | $3,023 |
| Vascepa Icosapent Ethyl | 730 | 860 | 164 | $297K |
| Gabapentin Generic | 681 | 872 | 219 | $2,123 |
| Amlodipine Besylate Generic | 623 | 887 | 139 | $1,345 |
| Tamsulosin Hcl Generic | 549 | 781 | 118 | $3,151 |
| Celecoxib Generic | 492 | 597 | 181 | $7,253 |
| Levocetirizine Dihydrochloride Generic | 487 | 644 | 148 | $2,931 |
| Olmesartan Medoxomil Generic | 486 | 756 | 123 | $3,774 |
| Losartan Potassium Generic | 468 | 769 | 115 | $2,920 |
| Triamcinolone Acetonide Generic | 449 | 485 | 174 | $3,558 |
| Farxiga Dapagliflozin Propanediol | 446 | 537 | 86 | $298K |
| Nebivolol Hcl Generic | 370 | 448 | 55 | $12K |
| Icosapent Ethyl Generic | 369 | 467 | 124 | $84K |
Brand drugs: 6,518 claims; generic drugs: 16,671 claims; opioid claims: 218.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nick Lee $6,176 ($6,176 in general payments such as food, travel and fees) from 30 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,385.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 42 | $1,385 |
| GlaxoSmithKline, LLC. GSK | 24 | $647 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 16 | $386 |
| Ardelyx, Inc. ARDX | 11 | $360 |
| IBSA Pharma Inc. | 22 | $336 |
| Amgen Inc. AMGN | 18 | $282 |
| Novo Nordisk Inc NVO | 12 | $249 |
| Abbvie Inc. ABBV | 10 | $245 |
| Lilly USA, LLC LLY | 8 | $202 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $179 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.